Understanding of COVID-19 based on current evidence
- PMID: 32096567
- PMCID: PMC7228250
- DOI: 10.1002/jmv.25722
Understanding of COVID-19 based on current evidence
Abstract
Since December 2019, a series of unexplained pneumonia cases have been reported in Wuhan, China. On 12 January 2020, the World Health Organization (WHO) temporarily named this new virus as the 2019 novel coronavirus (2019-nCoV). On 11 February 2020, the WHO officially named the disease caused by the 2019-nCoV as coronavirus disease (COVID-19). The COVID-19 epidemic is spreading all over the world, especially in China. Based on the published evidence, we systematically discuss the characteristics of COVID-19 in the hope of providing a reference for future studies and help for the prevention and control of the COVID-19 epidemic.
Keywords: 2019-nCoV; COVID-19; SARS-CoV-2; coronavirus; epidemiology; pneumonia.
© 2020 Wiley Periodicals, Inc.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Comment in
-
Latest updates on COVID-2019: A changing paradigm shift.J Med Virol. 2020 Jun;92(6):533-535. doi: 10.1002/jmv.25760. Epub 2020 Mar 20. J Med Virol. 2020. PMID: 32196703 Free PMC article. No abstract available.
Similar articles
-
The Wuhan SARS-CoV-2-What's next for China.J Med Virol. 2020 Jun;92(6):546-547. doi: 10.1002/jmv.25738. Epub 2020 Mar 18. J Med Virol. 2020. PMID: 32115732 Free PMC article. No abstract available.
-
Coronavirus Disease 2019: Clinical Review.Acta Med Port. 2020 Jul 1;33(7-8):505-511. doi: 10.20344/amp.13957. Epub 2020 Jun 4. Acta Med Port. 2020. PMID: 32498762 Review.
-
Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?Antiinflamm Antiallergy Agents Med Chem. 2020;19(2):85-87. doi: 10.2174/1871523019999200228100917. Antiinflamm Antiallergy Agents Med Chem. 2020. PMID: 32213152 No abstract available.
-
Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.Exp Biol Med (Maywood). 2020 Jun;245(11):964-969. doi: 10.1177/1535370220920540. Epub 2020 Apr 19. Exp Biol Med (Maywood). 2020. PMID: 32306751 Free PMC article. Review.
-
Clinical trial analysis of 2019-nCoV therapy registered in China.J Med Virol. 2020 Jun;92(6):540-545. doi: 10.1002/jmv.25733. Epub 2020 Mar 5. J Med Virol. 2020. PMID: 32108352 Free PMC article. Review.
Cited by
-
Is butyrate a natural alternative to dexamethasone in the management of CoVID-19?F1000Res. 2021 Apr 6;10:273. doi: 10.12688/f1000research.51786.1. eCollection 2021. F1000Res. 2021. PMID: 34046165 Free PMC article. Review.
-
Risk factors for mortality among patients with SARS-CoV-2 infection: A longitudinal observational study.J Med Virol. 2021 Apr;93(4):2021-2028. doi: 10.1002/jmv.26560. Epub 2020 Oct 10. J Med Virol. 2021. PMID: 32986248 Free PMC article.
-
A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece.Medicina (Kaunas). 2020 Jul 17;56(7):355. doi: 10.3390/medicina56070355. Medicina (Kaunas). 2020. PMID: 32708858 Free PMC article.
-
Knowledge, Attitude, and Practice of Physiotherapists in COVID-19 ICUs: A National Survey.ScientificWorldJournal. 2024 Jan 17;2024:9918558. doi: 10.1155/2024/9918558. eCollection 2024. ScientificWorldJournal. 2024. PMID: 38268747 Free PMC article.
-
The Impact of COVID-19 on the Neck of Femur Fracture Service in a Tertiary Care Hospital in the United Kingdom.Cureus. 2023 Oct 18;15(10):e47298. doi: 10.7759/cureus.47298. eCollection 2023 Oct. Cureus. 2023. PMID: 38021733 Free PMC article.
References
-
- Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome‐related coronavirus: The species and its viruses‐a statement of the coronavirus study group. bioRxiv. 2020. 10.1101/2020.02.07.937862 - DOI
-
- National Health Commission's briefing on the pneumonia epidemic situation (in Chinese). 2020. http://www.nhc.gov.cn/yjb/s7860/202001/9614b05a8cac4ffabac10c4502fe517c..... Accessed 23 February 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous